NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse

被引：28

作者：

Clarke, Sarah ^{[1
]}

O'Reilly, John ^{[1
,2
]}

Romeo, Giuliana ^{[1
,2
]}

Cooney, Julian

机构：

[1] Royal Perth Hosp, Dept Hematol, PathW Lab Med WA, Perth, WA 6847, Australia

[2] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia

来源：

LEUKEMIA RESEARCH | 2011年 / 35卷 / 07期

关键词：

AMPLIFIED EPISOMES; FUSION; AMPLIFICATION; ABL1;

D O I：

10.1016/j.leukres.2011.03.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E131 / E133

页数：3

共 6 条

[1] NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance [J].

Ballerini, P ;

Busson, M ;

Fasola, S ;

van den Akker, J ;

Lapillonne, H ;

Romana, SP ;

Marynen, P ;

Bernard, OA ;

Landman-Parker, J ;

Berger, R .

LEUKEMIA, 2005, 19 (03) :468-470

[2] Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia [J].

Deenik, W. ;

Beverloo, H. B. ;

van der Poel-van de Luytgaarde, S. C. P. A. M. ;

Wattel, M. M. ;

van Esser, J. W. J. ;

Valk, P. J. M. ;

Cornelissen, J. J. .

LEUKEMIA, 2009, 23 (03) :627-629

[3] Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia [J].

Graux, C ;

Cools, J ;

Melotte, C ;

Quentmeier, H ;

Ferrando, A ;

Levine, R ;

Vermeesch, JR ;

Stul, M ;

Dutta, B ;

Boeckx, N ;

Bosly, A ;

Heimann, P ;

Uyttebroeck, A ;

Mentens, N ;

Somers, R ;

MacLeod, RAF ;

Drexler, HG ;

Look, AT ;

Gilliland, DG ;

Michaux, L ;

Vandenberghe, P ;

Wlodarska, I ;

Marynen, P ;

Hagemeijer, A .

NATURE GENETICS, 2004, 36 (10) :1084-1089

[4] Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia [J].

Graux, C. ;

Stevens-Kroef, M. ;

Lafage, M. ;

Dastugue, N. ;

Harrison, C. J. ;

Mugneret, F. ;

Bahloula, K. ;

Struski, S. ;

Gregoire, M. J. ;

Nadal, N. ;

Lippert, E. ;

Taviaux, S. ;

Simons, A. ;

Kuiper, R. P. ;

Moorman, A. V. ;

Barber, K. ;

Bosly, A. ;

Michaux, L. ;

Vandenberghe, P. ;

Lahortiga, I. ;

De Keersmaecker, K. ;

Wlodarska, I. ;

Cools, J. ;

Hagemeijer, A. ;

Poirel, H. A. .

LEUKEMIA, 2009, 23 (01) :125-133

[5] Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies [J].

Quintas-Cardama, A. ;

Tong, W. ;

Manshouri, T. ;

Vega, F. ;

Lennon, P. A. ;

Cools, J. ;

Gilliland, D. G. ;

Lee, F. ;

Cortes, J. ;

Kantarjian, H. ;

Garcia-Manero, G. .

LEUKEMIA, 2008, 22 (06) :1117-1124

[6] Fusion of NUP214 to ABL1 on amplified episomes in T-ALL - implications for treatment [J].

Stergianou, K ;

Fox, C ;

Russell, N .

LEUKEMIA, 2005, 19 (09) :1680-1681

← 1 →